Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere
Open Access
- 1 January 1995
- journal article
- research article
- Published by Elsevier BV in Structure
- Vol. 3 (1), 33-40
- https://doi.org/10.1016/s0969-2126(01)00133-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Influence of stereochemistry on activity and binding modes for C2 symmetry-based diol inhibitors of HIV-1 proteaseJournal of the American Chemical Society, 1994
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures.Proceedings of the National Academy of Sciences of the United States of America, 1993
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostereJournal of Medicinal Chemistry, 1991
- Comparative analysis of the sequences and structures of HIV‐1 and HIV‐2 proteasesProteins-Structure Function and Bioinformatics, 1991
- Molecular Targets for AIDS TherapyScience, 1990
- Active human immunodeficiency virus protease is required for viral infectivity.Proceedings of the National Academy of Sciences, 1988
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967
- Traitement statistique des erreurs dans la determination des structures cristallinesActa Crystallographica, 1952